FLOVOVERMIC® LARGE BREED - Oral Tablet
Broad spectrum internal anti-parasite.
Broad spectrum internal antiparasitic in a single dose. Effective against nematodes and cestodes, such as: Toxocara canis, Toxascaris leonina, Trichuris vulpis, Ancylostoma caninum, Uncinaria stenocephala, Trichostrongilus sp., Taenia hydatigena, Taenia pisiformis, Taenia multiceps, Taenia serialis, Diphmis taenia serialis, and Diphmis taenia serialis canothinuminumidiforum, and Taenia serialis canothinumuminumidiforum. granulosus.
Technical Specification
Species
Large breed dogs (35 Kg).
Dosage form
Oral Tablet.
Therapeutic action
Broad spectrum internal anti-parasite.
Composition
Each tablet contains:
Flubendazole...................... 770 mg
Praziquantel........................175 mg
Pyrantel Pamoato.................504 mg
(Equivalent to 175 mg Pyrantel)
Excipients q.s.p....................1 tablet
Indications
Broad spectrum internal antiparasitic in a single dose. Effective against nematodes and cestodes, such as: Toxocara canis, Toxascaris leonina, Trichuris vulpis, Ancylostoma caninum, Uncinaria stenocephala, Trichostrongilus sp., Taenia hydatigena, Taenia pisiformis, Taenia multiceps, Taenia serialis, Diphmis taenia serialis, and Diphmis taenia serialis canothinuminumidiforum, and Taenia serialis canothinumuminumidiforum. granulosus.
Route od administration and dosage
Oral route, directly into the mouth or mixed with the food.
Dosage of active ingredients:
- Flubendazole: 22 mg / Kg of weight, in a single dose.
- Pyrantel: 5 mg / Kg of weight, in a single dose.
- Praziquantel: 5 mg / Kg of weight, in a single dose.
Product dosage:
1 tablet every 35 Kg of weight in a single dose. For the treatment of Trichuris vulpis infestations, administer 1 tablet every 24 hours, for 3 consecutive days.
Contraindications
- Do not administer to dogs under 4 weeks of age.
- Do not administer to pregnant or lactating females.
Warnings
- Keep out of reach of children.
Adverse effects
Adverse effects are rarely observed and if they occur they are mild and transitory, with gastrointestinal symptoms such as nausea, vomiting, anorexia, abdominal pain and diarrhea being observed.
Observations
Special precautions for disposal of unused product or waste material:
Discard any unused product remains in its original container. Do not throw the empty container or with product remains, in rivers, lakes or streams of water. Dispose of the waste of this product with care together with household waste.
Conservation
Storage in a cool and dry place, at room temperature between 15° y 30°C, protected from sunlight.
Condition of sale
To be supply only on veterinary prescription.
Presentation
Box with 20 tablets.
Prepared by
Drag Pharma Laboratory.
Records
Chile: Reg. SAG Nº: 1390
Perú: Registro SENASA F.08.21.I.1058
Bolivia: Reg. SENASAG PUV- Nº 10003/21
Countries where it is marketed
Imported and Distributed in Peru by:
Representaciones Durand SAC.
Av. Manuel Olguín No. 501 Office No. 604 Santiago de Surco Lima.
Imported and distributed in Bolivia by:
ZOOFARMA
TEL: +(591)222-3357
Street Díaz Romero 1339, La Paz.
You have entered drug info or veterinary products intended exclusively (s) kind (s) indicated (s).
Drag Pharma Lab is not responsible for the consequences of misuse of the products, and the use of this information without consulting a veterinarian